Considering both serum CRP and obesity status play an important role in the risk assessment of cardiovascular disease, both genetic and environmental factors need to be considered when interpreting the health risks indicated by serum CRP levels in clinical settings, especially among rare mutation carriers. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.